These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 30033244)

  • 1. Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.
    Li N; Lu W; Yu J; Xiao Y; Liu S; Gan L; Huang J
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():179-189. PubMed ID: 30033244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of Cellulose-Nanocrystal-Based Folate Targeted Nanomedicine via Layer-by-Layer Assembly with Lysosomal pH-Controlled Drug Release into the Nucleus.
    Li N; Zhang H; Xiao Y; Huang Y; Xu M; You D; Lu W; Yu J
    Biomacromolecules; 2019 Feb; 20(2):937-948. PubMed ID: 30621397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photo- and pH-Responsive Polycarbonate Block Copolymer Prodrug Nanomicelles for Controlled Release of Doxorubicin.
    Kalva N; Uthaman S; Augustine R; Jeon SH; Huh KM; Park IK; Kim I
    Macromol Biosci; 2020 Aug; 20(8):e2000118. PubMed ID: 32567108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomicelle drug with acid-triggered doxorubicin release and enhanced cellular uptake ability based on mPEG-graft-poly(N-(2-aminoethyl)-L-aspartamide)-hexahydrophthalic acid copolymers.
    Cao L; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    J Biomater Appl; 2018 Jan; 32(6):826-838. PubMed ID: 29132238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-doxorubicin conjugate prodrug as drug self-delivery system for intracellular pH-triggered slow release.
    Li J; Li X; Liu P
    Colloids Surf B Biointerfaces; 2020 Jan; 185():110608. PubMed ID: 31707225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading.
    Gatti S; Agostini A; Palmiero UC; Colombo C; Peviani M; Biffi A; Moscatelli D
    Nanotechnology; 2018 Jul; 29(30):305602. PubMed ID: 29701613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of antitumor activity of acid-sensitive PEGylated doxorubicin.
    Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
    ACS Appl Mater Interfaces; 2014 Dec; 6(23):21202-14. PubMed ID: 25415351
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Dong Y; Du P; Liu P
    Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Indicating Polymer Prodrug Nanoparticles for pH-Responsive Drug Delivery in Cancer Cells and Real-Time Monitoring of Drug Release.
    Kayal S; Kola P; Pal J; Mandal M; Dhara D
    ACS Appl Bio Mater; 2024 Sep; 7(9):5810-5822. PubMed ID: 39186444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery.
    Song H; Zhang J; Wang W; Huang P; Zhang Y; Liu J; Li C; Kong D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():365-74. PubMed ID: 26433349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery.
    Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y
    Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
    Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully glutathione degradable waterborne polyurethane nanocarriers: Preparation, redox-sensitivity, and triggered intracellular drug release.
    Omrani I; Babanejad N; Shendi HK; Nabid MR
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):607-616. PubMed ID: 27770933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
    Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
    Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.